Vimarsana
Biggest News Aggregation in the World

Page 33 - Docket Number News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Docket Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Docket Number Today - Breaking & Trending Today

Cybersecurity in Medical Devices: Refuse to Accept Policy for Cyber Devices and Related Systems Under Section 524B of the FD&C Act - Vimarsana News

Cybersecurity in Medical Devices: Refuse to Accept Policy for Cyber Devices and Related Systems Under Section 524B of the FD&C Act

This guidance describes FDA's RTA policy for premarket submissions submitted for cyber devices before October 1, 2023.

Source: fda.gov
FDA Revamps Guidance Concerning Use of Electronic Systems, Records, and Signatures in Clinical Investigations | Nelson Mullins Riley & Scarborough LLP - Vimarsana News

FDA Revamps Guidance Concerning Use of Electronic Systems, Records, and Signatures in Clinical Investigations | Nelson Mullins Riley & Scarborough LLP

The U.S. Food and Drug Administration (FDA) has published updated draft guidance for industry, Electronic Systems, Electronic Records, and Electronic Signatures in Clinical...

Soft (Hydrophilic) Daily Wear Contact Lenses - Performance Criteria for Safety and Performance Based Pathway - Vimarsana News

Soft (Hydrophilic) Daily Wear Contact Lenses - Performance Criteria for Safety and Performance Based Pathway

Final guidance provides performance criteria for soft daily wear contact lenses (21 CFR 886.5925, LPL) in support of the Safety and Performance Based Pathway.

Source: fda.gov
General Considerations for Animal Studies Intended to Evaluate Medical Devices - Vimarsana News

General Considerations for Animal Studies Intended to Evaluate Medical Devices

FDA developed this guidance document to outline general considerations for certain animal studies used to support device premarket submissions.

Source: fda.gov
Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics - Vimarsana News

Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics

Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics

Source: fda.gov